MSF and DNDi call for scale-up of R&D for neglected diseases
Feb 23 2009
Some 500 million people worldwide are at risk from sleeping sickness, visceral leishmaniasis, and Chagas disease, but those deadly ailments receive less than 5 percent of the global research and development (R&D) funds allocated even to neglected diseases.
To read the MSF press release in English
Neglected Diseases ‘Need Sustainable Funding’
WASHINGTON, Feb 24 (OneWorld.net) – Millions of people are suffering and dying needlessly from diseases whose potential treatments don’t promise to turn a profit for drug companies, warned doctors and humanitarian aid workers yesterday.